Javier Escalada, F., Halimi, S., Senior, P. A., Bonnemaire, M., Cali, A. M. G., Melas‐Melt, L., . . . Ritzel, R. A. (2018). Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment. Diabetes Obes Metab.

Javier Escalada, F., Serge Halimi, Peter A. Senior, Mireille Bonnemaire, Anna M. G. Cali, Lydie Melas‐Melt, Janaka Karalliedde, und Robert A. Ritzel. "Glycaemic Control and Hypoglycaemia Benefits With Insulin Glargine 300 U/mL Extend to People With Type 2 Diabetes and Mild‐to‐moderate Renal Impairment." Diabetes Obes Metab 2018.

Javier Escalada, F., et al. "Glycaemic Control and Hypoglycaemia Benefits With Insulin Glargine 300 U/mL Extend to People With Type 2 Diabetes and Mild‐to‐moderate Renal Impairment." Diabetes Obes Metab 2018.